Affini-T Therapeutics
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- $66M
Investors
- 9
About Affini-T Therapeutics
Founded in 2020, and based in Massachusetts, the US, Affini-T Therapeutics, Inc. operates as a biotechnology company that is developing T-cell therapies for cancer patients. Jak Knowles (CEO), Loïc Vincent (CSO), Kim Nguyen, (CTO), and Kathy Yi (COO) are the co-founders of the company. In March 2022, Affini-T Therapeutics, Inc. The company offers a therapeutics platform that provides immune cell technology that unlocks the power of T cells while targeting core oncogenic drivers to develop potentially curative therapies for solid tumor cancers. The firm's cell therapy platform uses cutting-edge engineering and synthetic biology to optimize T-cell functions and rewrite the rules of the solid tumor microenvironment, allowing for the possibility of long-term clinical outcomes in patients.
Who invested in Affini-T Therapeutics
9 investors across 1 round
See all investors in Affini-T Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 22, 2022
Amount
$66M
Investors
Questions about Affini-T Therapeutics
Who invested in Affini-T Therapeutics?
Affini-T Therapeutics has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Affini-T Therapeutics raised?
Affini-T Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Affini-T Therapeutics last raise money?
Affini-T Therapeutics's most recent round on record is a Series B, in Mar 2022.
What does Affini-T Therapeutics do?
Founded in 2020, and based in Massachusetts, the US, Affini-T Therapeutics, Inc.
Where is Affini-T Therapeutics headquartered?
Affini-T Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Affini-T Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Affini-T Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Affini-T Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.